Insulin release in impaired glucose tolerance: Oral minimal model predicts normal sensitivity to glucose but defective response times

Diabetes

Volumn 51, Issue SUPPL., 2002, Pages

  Breda, Elena ^a   Toffolo, Gianna ^a   Polonsky, Kenneth S ^b   Cobelli, Claudio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; CASE REPORT; COMPARTMENT MODEL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MATHEMATICAL MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL MINIMAL MODEL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RESPONSE TIME;

EID: 0036311152     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s227     Document Type: Conference Paper

References (25)

1. Porte D Jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: Evidence for a hyperbolic function
2. Calculated pattern of interportal insulin appearance without independent assessment of C-peptide kinetics
3. Pre-hepatic beta-cell secretion during the intravenous glucose tolerance test in humans: Application of a combined model of insulin and C-peptide kinetics
4. Estimation of β-cell sensitivity from IVGTT C-peptide data: Knowledge of the kinetics avoids errors in modeling the secretion
5. Beta cell function during insulin modified IVGTT successfully assessed by the C-peptide minimal model
6. Insulin secretion and clearance during low-dose graded glucose infusion
7. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
8. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis and fibrinolysis in women with polycystic ovary syndrome
9. Pancreatic β cell responsiveness during meal tolerance test: Model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus
10. Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion
11. A model for glucose control of insulin secretion during 24 h of free living
12. Quantitative indexes of β cell function during graded up-and-down glucose infusion from C-peptide minimal models
13. Oral glucose tolerance test minimal model indexes of β-cell function and insulin sensitivity
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
15. Immunoassay of insulin; two antibody system; plasma insulin levels of normal, subdiabetic and diabetic rats
16. Characterization of seven C-peptide antisera
17. Nonparametric input estimation in physiological systems: Problems, methods, case studies
18. Prehepatic insulin production in man: Kinetic analysis using peripheral connecting peptide behaviour
19. Quantitative estimation of insulin sensitivity
20. WINSTODEC: A stochastic deconvolution interactive program for physiological and pharmacokinetic systems
21. SAAM II: Simulation, analysis and modeling software for tracer and pharmacokinetic studies
22. Estimation of insulin secretion rates from C-peptide levels: Comparison of individual and standard kinetic parameters for C-peptide clearance
23. Insulin and C-peptide levels after oral and intravenous glucose: Contribution of enteroinsular axis to insulin secretion